News
Lines of Therapy for Locally Advanced/Metastatic Urothelial Carcinoma: The New Paradigm To truly attain high-quality, goal-congruent care at the end of life, collaborations with patients, their ...
Pancreatic adenocarcinoma remains one of the most aggressive and difficult-to-treat solid tumor malignancies, with a high mortality-to-incidence ratio. Globally, pancreatic cancer ranks 12th in terms ...
Toward Functional Biomarkers of Response to Neoadjuvant Oncolytic Virus in Stage II Melanoma: Immune-Förster Resonance Energy Transfer and the Dynamic Tumor Immune Microenvironment Twenty-eight ...
Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma The AI models predicted disease-free survival ...
Cancers are predominantly characterized by their genomic aberrations, but over the past decades, there has also been an increasing focus on epigenetic alterations in cancer biology. 12-15 Although ...
Patterns of Complementary Medicine Utilization in Patients With Breast Cancer and Colorectal Cancer: A Cross-Sectional Study at a Tertiary Referral Hospital in Yogyakarta, Indonesia A total of 819 ...
Pacific Peoples' Experiences of Cancer and Its Treatment in Aotearoa New Zealand Through Talanoa: A Qualitative Study of Samoan and Tongan Participants This open-label phase I study enrolled patients ...
Real-World Analysis Evaluating Treatment Eligibility and Outcomes in Patients With AML Receiving Intensive Chemotherapy: Insights From an Underrepresented Population Adj PD-1 therapy did not improve ...
An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last The review by Hazim et al 1 in this journal outlines ongoing and planned major clinical trials in extensive-stage ...
Feasibility and Acceptability of Collecting Passive Smartphone Data for Potential Use in Digital Phenotyping Among Family Caregivers and Patients With Advanced Cancer Endocrine treatments for patients ...
The January 24, 2025, article by Rha et al entitled “Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III ...
Methotrexate, Doxorubicin, and Cisplatin Versus Methotrexate, Doxorubicin, and Cisplatin + Ifosfamide in Poor Responders to Preoperative Chemotherapy for Newly Diagnosed High-Grade Osteosarcoma ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results